Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
12432 | 906 | 48.1 | 85% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
11 | 4 | NEUROSCIENCES//CLINICAL NEUROLOGY//NEUROL | 1112395 |
76 | 3 | NEUROSCIENCES//DOPAMINE//SEROTONIN | 81359 |
446 | 2 | AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS//5 HTTLPR//PSYCHIATRIC GENETICS | 16189 |
12432 | 1 | DRD3//TARDIVE DYSKINESIA//HTR2A | 906 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | DRD3 | authKW | 365405 | 3% | 36% | 30 |
2 | TARDIVE DYSKINESIA | authKW | 356614 | 10% | 11% | 93 |
3 | HTR2A | authKW | 285445 | 3% | 35% | 24 |
4 | PHARMACOGENET CLIN | address | 233163 | 2% | 43% | 16 |
5 | HTR2C | authKW | 210620 | 2% | 42% | 15 |
6 | T102C POLYMORPHISM | authKW | 206423 | 1% | 88% | 7 |
7 | PHARMACOGENETICS | authKW | 196972 | 17% | 4% | 157 |
8 | NEUROGENET SECT | address | 170451 | 6% | 10% | 51 |
9 | ANTIPSYCHOTICS | authKW | 161587 | 17% | 3% | 151 |
10 | 5 HT2A RECEPTOR GENE | authKW | 151650 | 1% | 50% | 9 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Psychiatry | 18339 | 51% | 0% | 462 |
2 | Pharmacology & Pharmacy | 3043 | 35% | 0% | 315 |
3 | Genetics & Heredity | 2688 | 23% | 0% | 212 |
4 | Neurosciences | 2658 | 33% | 0% | 295 |
5 | Clinical Neurology | 895 | 15% | 0% | 135 |
6 | Psychology | 295 | 4% | 0% | 40 |
7 | Biotechnology & Applied Microbiology | 11 | 3% | 0% | 28 |
8 | Medical Laboratory Technology | 8 | 1% | 0% | 7 |
9 | Biochemistry & Molecular Biology | 7 | 8% | 0% | 68 |
10 | Substance Abuse | 5 | 1% | 0% | 5 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | PHARMACOGENET CLIN | 233163 | 2% | 43% | 16 |
2 | NEUROGENET SECT | 170451 | 6% | 10% | 51 |
3 | BIOMARKER PERSONALIZED MED | 71004 | 2% | 15% | 14 |
4 | PL PHARMACOL MEMBRANE BIOL SIGNAL TRANSDUCT M | 67404 | 0% | 100% | 2 |
5 | DISCIPLINE PEDOPSYCHIAT | 44935 | 0% | 67% | 2 |
6 | NEUROGENET SECT ADDICT MENTAL HLTH | 44935 | 0% | 67% | 2 |
7 | PEDOPSYCHIAT DISCIPLINE | 44935 | 0% | 67% | 2 |
8 | PATHOL ANAT PHARMACOL MICROBIOL | 42120 | 1% | 25% | 5 |
9 | BRAIN KOREA BIOMED SCI 21 | 37429 | 1% | 11% | 10 |
10 | ANAT PATHOL PHARMACOL MICROBIOL | 36686 | 1% | 16% | 7 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | PHARMACOGENOMICS JOURNAL | 49313 | 4% | 4% | 34 |
2 | PSYCHIATRIC GENETICS | 45907 | 4% | 4% | 35 |
3 | PHARMACOGENOMICS | 30404 | 4% | 2% | 40 |
4 | AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS | 18806 | 4% | 2% | 32 |
5 | MOLECULAR PSYCHIATRY | 14200 | 3% | 1% | 31 |
6 | PHARMACOGENETICS AND GENOMICS | 13077 | 2% | 2% | 21 |
7 | HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL | 8665 | 2% | 1% | 21 |
8 | AMERICAN JOURNAL OF MEDICAL GENETICS | 5811 | 4% | 0% | 39 |
9 | JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY | 5463 | 2% | 1% | 21 |
10 | PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY | 4618 | 3% | 1% | 26 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | DRD3 | 365405 | 3% | 36% | 30 | Search DRD3 | Search DRD3 |
2 | TARDIVE DYSKINESIA | 356614 | 10% | 11% | 93 | Search TARDIVE+DYSKINESIA | Search TARDIVE+DYSKINESIA |
3 | HTR2A | 285445 | 3% | 35% | 24 | Search HTR2A | Search HTR2A |
4 | HTR2C | 210620 | 2% | 42% | 15 | Search HTR2C | Search HTR2C |
5 | T102C POLYMORPHISM | 206423 | 1% | 88% | 7 | Search T102C+POLYMORPHISM | Search T102C+POLYMORPHISM |
6 | PHARMACOGENETICS | 196972 | 17% | 4% | 157 | Search PHARMACOGENETICS | Search PHARMACOGENETICS |
7 | ANTIPSYCHOTICS | 161587 | 17% | 3% | 151 | Search ANTIPSYCHOTICS | Search ANTIPSYCHOTICS |
8 | 5 HT2A RECEPTOR GENE | 151650 | 1% | 50% | 9 | Search 5+HT2A+RECEPTOR+GENE | Search 5+HT2A+RECEPTOR+GENE |
9 | T102C | 150122 | 1% | 64% | 7 | Search T102C | Search T102C |
10 | SCHIZOPHRENIA | 125635 | 40% | 1% | 358 | Search SCHIZOPHRENIA | Search SCHIZOPHRENIA |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | ZHANG, JP , MALHOTRA, AK , (2011) PHARMACOGENETICS AND ANTIPSYCHOTICS: THERAPEUTIC EFFICACY AND SIDE EFFECTS PREDICTION.EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY. VOL. 7. ISSUE 1. P. 9 -37 | 133 | 73% | 69 |
2 | ARRANZ, MJ , RIVERA, M , MUNRO, JC , (2011) PHARMACOGENETICS OF RESPONSE TO ANTIPSYCHOTICS IN PATIENTS WITH SCHIZOPHRENIA.CNS DRUGS. VOL. 25. ISSUE 11. P. 933-969 | 168 | 61% | 39 |
3 | BRANDL, EJ , KENNEDY, JL , MULLER, DJ , (2014) PHARMACOGENETICS OF ANTIPSYCHOTICS.CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE. VOL. 59. ISSUE 2. P. 76 -88 | 107 | 66% | 19 |
4 | KOHLRAUSCH, FB , (2013) PHARMACOGENETICS IN SCHIZOPHRENIA: A REVIEW OF CLOZAPINE STUDIES.REVISTA BRASILEIRA DE PSIQUIATRIA. VOL. 35. ISSUE 3. P. 305 -317 | 99 | 66% | 8 |
5 | GRESSIER, F , PORCELLI, S , CALATI, R , SERRETTI, A , (2016) PHARMACOGENETICS OF CLOZAPINE RESPONSE AND INDUCED WEIGHT GAIN: A COMPREHENSIVE REVIEW AND META-ANALYSIS.EUROPEAN NEUROPSYCHOPHARMACOLOGY. VOL. 26. ISSUE 2. P. 163 -185 | 68 | 76% | 2 |
6 | ZANDI, PP , JUDY, JT , (2010) THE PROMISE AND REALITY OF PHARMACOGENETICS IN PSYCHIATRY.CLINICS IN LABORATORY MEDICINE. VOL. 30. ISSUE 4. P. 931-+ | 171 | 38% | 10 |
7 | ZANDI, PP , JUDY, JT , (2010) THE PROMISE AND REALITY OF PHARMACOGENETICS IN PSYCHIATRY.PSYCHIATRIC CLINICS OF NORTH AMERICA. VOL. 33. ISSUE 1. P. 181-+ | 167 | 37% | 15 |
8 | ARRANZ, MJ , DE LEON, J , (2007) PHARMACOGENETICS AND PHARMACOGENOMICS OF SCHIZOPHRENIA: A REVIEW OF LAST DECADE OF RESEARCH.MOLECULAR PSYCHIATRY. VOL. 12. ISSUE 8. P. 707 -747 | 115 | 39% | 196 |
9 | TSERMPINI, EE , ASSIMAKOPOULOS, K , BARTSAKOULIA, M , ICONOMOU, G , PAPADIMA, EM , MITROPOULOS, K , SQUASSINA, A , PATRINOS, GP , (2014) INDIVIDUALIZING CLOZAPINE AND RISPERIDONE TREATMENT FOR SCHIZOPHRENIA PATIENTS.PHARMACOGENOMICS. VOL. 15. ISSUE 1. P. 95 -110 | 80 | 62% | 1 |
10 | TAN, JJ , CHEN, S , SU, L , LONG, JX , XIE, JJ , SHEN, TT , JIANG, J , GU, L , (2014) ASSOCIATION OF THE T102C POLYMORPHISM IN THE HTR2A GENE WITH MAJOR DEPRESSIVE DISORDER, BIPOLAR DISORDER, AND SCHIZOPHRENIA.AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS. VOL. 165. ISSUE 5. P. 438 -455 | 57 | 67% | 6 |
Classes with closest relation at Level 1 |